Involvement of p27KIP1 in the proliferation of the developing corneal endothelium

Kazuhiko Yoshida1, Satoru Kase, Keiko Nakayama

  • 1Department of Ophthalmology, Hokkaido University School of Medicine, Sapporo, Japan. kyoshida@med.hokudai.ac.jp

Insights

The protein p27(KIP1) regulates the proliferation of corneal endothelial cells during development. Loss of p27(KIP1) in mice leads to increased endothelial cell proliferation, highlighting its crucial role.

Area of Science:

  • Ophthalmology
  • Developmental Biology
  • Cell Cycle Regulation

Background:

  • The corneal endothelium is crucial for maintaining corneal clarity and is a slowly renewing tissue.
  • Understanding the regulatory mechanisms governing corneal endothelial cell proliferation is vital for regenerative medicine and treating corneal diseases.

Purpose of the Study:

  • To investigate the role of p27(KIP1), a cell cycle inhibitor, in regulating the proliferation of developing corneal endothelial cells.
  • To determine the impact of p27(KIP1) deficiency on corneal endothelial cell numbers and proliferation.

Main Methods:

  • Immunocytochemistry was used to detect p27(KIP1) and PCNA in mouse corneas at different developmental stages.
  • Whole-mount analysis and bromodeoxyuridine (BrdU) cell-proliferation assays were performed on wild-type and p27(KIP1) knockout mice.

Main Results:

  • p27(KIP1) expression increased in corneal endothelial cells from postnatal day 1 to 12 weeks.
  • PCNA, a proliferation marker, was abundant early but decreased significantly with age in wild-type mice.
  • p27(KIP1) knockout mice showed significantly higher endothelial cell numbers and increased BrdU incorporation compared to controls.

Conclusions:

  • p27(KIP1) plays a significant role in inhibiting corneal endothelial cell proliferation during development.
  • The findings suggest p27(KIP1) is a key regulator controlling the quiescent state of the adult corneal endothelium.
Abstract

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.